![]() Puma Biotechnology Puma Biotechnology acquires and develops innovative products for the treatment of various forms of cancer. | ||
Founding Date | Founding Date 2010 | Founding Date 2015 |
Type | Type Public | Type Public |
Tags | ||
Locations | Locations Los Angeles, US HQ | Locations Woburn, US HQ Milton, GB Woburn, US |
Employees | Employees 27214% decrease | Employees 10422% increase |
Valuation ($) | Valuation ($) 136.8 m | Valuation ($) 823.3 m |
Funding | ||
Total funding raised | Total funding raised $ 172m | Total funding raised $ 30m |

Replimune Ltd. develops oncolytic immunotherapies for the treatment of cancer.
View company